Related Experiment Video

Updated: Mar 20, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Anticancer activity of 7,8-dihydroxyflavone in melanoma cells via downregulation of α-MSH/cAMP/MITF pathway

Deok Yong Sim1, Jae Kyung Sohng1, Hye Jin Jung1

  • 1Department of BT-Convergent Pharmaceutical Engineering, Sun Moon University, Chungnam 336-708, Republic of Korea.

Oncology Reports
|May 26, 2016
PubMed

Insights

7,8-dihydroxyflavone (7,8-DHF) effectively inhibits melanoma cell growth, migration, and invasion. This compound also reduces melanogenesis and melanoma progression by downregulating key transcription factors, offering potential in melanoma treatment.

Area of Science:

  • Biochemistry
  • Dermatology
  • Pharmacology

Background:

  • Malignant melanoma is an aggressive skin cancer resistant to conventional therapies.
  • Identifying novel therapeutic agents is crucial for effective melanoma treatment.

Purpose of the Study:

  • To investigate the anticancer effects and mechanisms of 7,8-dihydroxyflavone (7,8-DHF) in melanoma cells.
  • To evaluate the potential of 7,8-DHF as a therapeutic agent for malignant melanoma.

Main Methods:

  • Assessing the effects of 7,8-DHF on B16F10 melanoma cell growth, survival, migration, and invasion.
  • Investigating the impact of 7,8-DHF on melanogenesis and tyrosinase activity.
  • Analyzing the molecular mechanisms involving microphthalmia-associated transcription factor (MITF), hypoxia-inducible factor 1α (HIF1α), c-MET, and cyclic adenosine monophosphate (cAMP) levels.
  • Evaluating combination therapy with 7,8-DHF and resveratrol.

Main Results:

  • 7,8-DHF inhibited melanoma cell growth, clonogenic survival, migration, and invasion without cytotoxicity.
  • 7,8-DHF demonstrated anti-melanogenic activity by inhibiting tyrosinase.
  • The compound downregulated MITF and its targets (HIF1α, c-MET) by decreasing cAMP levels.
  • Combination therapy with 7,8-DHF and resveratrol showed enhanced anticancer effects.

Conclusions:

  • 7,8-DHF exhibits significant anticancer properties against melanoma cells.
  • The mechanism involves the downregulation of MITF signaling pathways.
  • 7,8-DHF holds promise for the prevention and treatment of malignant melanoma, potentially enhanced by combination therapy.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K